News
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
The payoff in lives and hospital time saved runs at about 100 to 1 per dollar invested, which is a great deal by any standard ...
New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...
BioNTech SE is currently sponsoring a Phase II clinical study titled A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell ...
1d
TipRanks on MSNBioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer
The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is being compared against standard chemotherapy drugs, doxorubicin or paclitaxel, ...
Released Tuesday, the AAP's recommendations call for routine vaccination of children ages 6 months to 2 years, citing ...
Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...
Texas school districts are coming back from summer with a rising number of parents asking for vaccine exemption forms and a ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results